<didl:DIDL xmlns:dip="urn:mpeg:mpeg21:2002:01-DIP-NS" xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:didl="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:dcterms="http://purl.org/dc/terms/" DIDLDocumentId="https://arxiv.universalpublishings.com/id/eprint/70307" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd urn:mpeg:mpeg21:2005:01-DIP-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dip/dip.xsd">
  <didl:Item>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dii:Identifier>https://arxiv.universalpublishings.com/id/eprint/70307</dii:Identifier>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dcterms:modified>2026-05-26T15:59:31Z</dcterms:modified>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Component>
      <didl:Resource mimeType="application/xml" ref="https://arxiv.universalpublishings.com/cgi/export/eprint/70307/DIDL/arxiv-eprint-70307.xml"/>
    </didl:Component>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/descriptiveMetadata</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/xml">
          <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:relation>https://arxiv.universalpublishings.com/id/eprint/70307/</dc:relation>
        <dc:title>CHARACTERISTICS OF IMMUNE DISORDERS IN CHRONIC PROSTATITIS DEPENDING ON THE PRESENCE OF METABOLIC SYNDROME IN YOUNG MEN</dc:title>
        <dc:creator>Raimovich, Juraev Shakhzod</dc:creator>
        <dc:description>The use of panavir in the complex of etiopathogenetic therapy of patients with chronic bacterial prostatitis in combina tion with metabolic syndrome statistically significantly improves the results of treatment of chronic prostatitis, indicators of lipid metab olism, increases the fertility of the ejaculate. There were no adverse reactions to the drug. Should include panavir in the standard of therapy for patients with chronic bacterial prostatitis.</dc:description>
        <dc:publisher>"XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR" nomli respublika ilmiy-amaliy konferensiyasi</dc:publisher>
        <dc:date>2025-08-22</dc:date>
        <dc:type>Maqola</dc:type>
        <dc:type>NonPeerReviewed</dc:type>
        <dc:identifier>  Raimovich, Juraev Shakhzod  (2025) CHARACTERISTICS OF IMMUNE DISORDERS IN CHRONIC PROSTATITIS DEPENDING ON THE PRESENCE OF METABOLIC SYNDROME IN YOUNG MEN.  XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR nomli respublika ilmiy-amaliy konferensiyasi.       </dc:identifier>
        <dc:relation>https://universalpublishings.com/index.php/itfttdm/article/view/13488</dc:relation>
        <dc:relation>oai:ojs.pkp.sfu.ca:article/13488</dc:relation>
        <dc:identifier>oai:ojs.pkp.sfu.ca:article/13488</dc:identifier></oai_dc:dc>
        </didl:Resource>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/humanStartPage</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource ref="https://arxiv.universalpublishings.com/id/eprint/70307/" mimeType="application/html"/>
      </didl:Component>
    </didl:Item>
  </didl:Item>
</didl:DIDL>